NEXLINA 5

NEXLINA 5 is a selective DPP-4 inhibitor that enhances the body’s natural incretin system, helping adults with type 2 diabetes regulate blood sugar levels more effectively. Supporting glucose-dependent insulin secretion and reducing excessive glucagon release, it aids in maintaining stable blood sugar throughout the day and reduces the risk of long-term complications.

COMPOSITION:

• Linagliptin 5 mg

MODE OF ACTION: Linagliptin inhibits dipeptidyl peptidase-4 (DPP-4), prolonging the activity of incretin hormones, which increase insulin release and decrease glucagon secretion in a glucose-dependent manner.

INDICATIONS:

• Management of type 2 diabetes mellitus in adults to improve blood glucose levels.
• Suitable as monotherapy or in combination with other antidiabetic agents.

DOSAGE:

• Recommended dose: 1 tablet once daily, with or without food.
• No dose adjustment required for mild to moderate renal impairment.

STORAGE: Store below 25ᵒC, protected from moisture and light.

DISCLAIMER: This information is intended for medical professionals and registered medical practitioners only. Use of this product should be under the supervision of a registered medical practitioner with a valid prescription.